Expression of retinoic acid receptor beta in dermatofibrosarcoma protuberans.
Retinoic acid receptor beta (RAR beta) has been shown to act as a tumor suppressor in many solid human tumors. To investigate the putative role of RAR beta in dermatofibrosarcoma protuberans (DFSP), we examined the expression of RAR beta in DFSPs and analyzed the correlation of expression patterns between RAR beta and cyclooxygenase (COX)-2 as well as clinicopathological variables. Using tissue microarray and immunohistochemistry, we evaluated nuclear RAR beta staining and cytoplasm COX-2 staining in 53 DFSPs. 48 DFSPs (90.58%) were immunopositive for RAR beta, while 32 DFSPs (60.38%) were immunopositive for COX-2. RAR beta staining was significantly inversely correlated with COX-2 staining (p < 0.001; r =-0.668). Our data indicated that RAR beta expressed in DFSPs and correlated with COX-2 expression. RAR beta may be a potential therapeutic target for unresectable DFSP cases.